BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20029206)

  • 1. A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
    Bai Y; Xu MJ; Yang X; Xu C; Gao J; Zou DW; Li ZS
    Digestion; 2010; 81(1):27-34. PubMed ID: 20029206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
    Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
    Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for the treatment of gastroparesis: a preliminary report.
    Lacy BE; Zayat EN; Crowell MD; Schuster MM
    Am J Gastroenterol; 2002 Jun; 97(6):1548-52. PubMed ID: 12094882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
    Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
    Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
    Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.
    Coleski R; Anderson MA; Hasler WL
    Dig Dis Sci; 2009 Dec; 54(12):2634-42. PubMed ID: 19184429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyloroplasty Offers Relief of Postfundoplication Gastroparesis in Patients Who Improved After Botulinum Toxin Injection.
    Gilsdorf D; Volckmann E; Brickley A; Taylor LJ; Glasgow RE; Fang J
    J Laparoendosc Adv Surg Tech A; 2017 Nov; 27(11):1180-1184. PubMed ID: 28481694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
    Rodriguez L; Rosen R; Manfredi M; Nurko S
    Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroparesis--diagnosis and treatment].
    Ciortescu I; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):330-8. PubMed ID: 21495337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for treatment of refractory gastroparesis.
    DeSantis ER; Huang S
    Am J Health Syst Pharm; 2007 Nov; 64(21):2237-40. PubMed ID: 17959574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapyloric injection of botulinum toxin a for the treatment of persistent gastroparesis following successful pancreas transplantation.
    Ben-Youssef R; Baron PW; Franco E; Walter MH; Lewis T; Ojogho O
    Am J Transplant; 2006 Jan; 6(1):214-8. PubMed ID: 16433778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond gastric emptying: a "toxic" lesson about gastroparesis.
    Pasricha PJ
    Am J Gastroenterol; 2008 Feb; 103(2):424-6. PubMed ID: 18289204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment of gastroparesis.
    McCarty TR; Rustagi T
    World J Gastroenterol; 2015 Jun; 21(22):6842-9. PubMed ID: 26078560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapyloric botulinum toxin injection improves gastric emptying.
    Woodward MN; Spicer RD
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):201-2. PubMed ID: 12883311
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin.
    Martin JT; Federico JA; McKelvey AA; Kent MS; Fabian T
    Ann Thorac Surg; 2009 Jun; 87(6):1708-13; discussion 1713-4. PubMed ID: 19463583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapyloric Botulinum Toxin A Injection for Gastroparesis and Functional Upper Gastrointestinal Symptoms in Children: Mayo Clinic Experience, Review of the Literature, and Meta-analysis.
    Ezaizi Y; Hasan B; Manini ML; Absah I
    Paediatr Drugs; 2022 Sep; 24(5):539-545. PubMed ID: 35768647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.